Travoprost
In Stock•Starting at $163 for 50 mg•Purity ≥ 98%
| CAS No. | 157283-68-6 |
|---|---|
| MDL No. | MFCD03411995 |
| MF | C26H35F3O6 |
| MW | 500.50 |
| InChI Key | MKPLKVHSHYCHOC-AHTXBMBWSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 50 mg | 98% | $163 | In Stock | |
| 100 mg | 98% | $196 | In Stock | |
| 250 mg | 98% | $316 | In Stock | |
| 1 g | 98% | $695 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Travoprost is the isopropyl ester of prostaglandin F2α, with the pentyl group replaced by a 3-(trifluoromethyl)phenoxymethyl group. It is a synthetic analogue of prostaglandin F2α used in ophthalmic solutions to control open-angle glaucoma and ocular hypertension by reducing intraocular pressure. As a prodrug, the isopropyl ester is hydrolyzed by corneal esterases to the active free acid, fluprostenol. It functions as an antiglaucoma drug, antihypertensive agent, prodrug, ophthalmology drug, and prostaglandin receptor agonist. It belongs to prostaglandins Fα, (trifluoromethyl)benzenes, and isopropyl esters, and is functionally related to fluprostenol.
| CAS No. | 157283-68-6 |
|---|---|
| Product Name | Travoprost |
Biological Targets
PTGFR
Associated Conditions
ocular hypertension·glaucoma·exfoliation syndrome·open-angle glaucoma
* The information provided here is compiled from public sources and is for reference only.
